Article

Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Aβ ratio

2025-04-09

Abstract excerpt

<h4>Background</h4> Alzheimer’s disease blood-based biomarkers are a cost-effective early-detection method that, for precision medicine reasons, needs to be studied in both Blackand White. Few studies have a long follow-up of cognition. We studied a blood-biomarkers panel, cognitive decline, and dementia risk in a large number of Black and White participants. <h4>Methods</h4> Participants without dementia were fol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6dee6011-90cd-5a19-be22-2fca91f3dc56
DOI: 10.1101/2025.04.07.25325417

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Aβ ratioDOI 10.1101/2025.04.07.25325417Read

The association of blood-based biomarkers of neuropathology with cognitive performance and incident dementia in a diverse, nationally-representative sample of US adultsSemantic proximity Read

Equity and Transportability of Plasma ATN Phenotypes in a Population-Representative U.S. Aging CohortSemantic proximity Read

Plasma biomarker levels and cognitive decline in a heterogenous community-based cohort with multiple comorbiditiesSemantic proximity Read

Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population studySemantic proximity Read

Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.Semantic proximity Read

Baseline levels and longitudinal rates of change in plasma Aβ42/40 among self-identified Black/African American and White individualsSemantic proximity Read

Population-based reference equations and Z-scores for blood biomarkers of neurodegenerative diseasesSemantic proximity Read

Blood-based biomarkers for Alzheimer’s disease: influence of kidney functionSemantic proximity Read

pTau217 in Admixed South American Populations: Implications for Alzheimer’s Disease Diagnosis in Brazil and ArgentinaSemantic proximity Read

Plasma biomarkers predict amyloid conversion and cognitive decline in cognitively unimpaired adultsSemantic proximity Read

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresSemantic proximity Read

Electronic health records to test multimorbidity influences to plasma biomarker interpretation for Alzheimer’s diseaseSemantic proximity Read